Embolization device constructed from expansile polymer

US2016166258A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016166258-A1
Application numberUS-201614990676-A
CountryUS
Kind codeA1
Filing dateJan 7, 2016
Priority dateJun 15, 2006
Publication dateJun 16, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.

First claim

Opening claim text (preview).

We claim: 1 . A device for occlusion of a lumen comprising: an elongated hydrogel configured to expand upon contact with an aqueous liquid at a physiological pH to form an expanded hydrogel, wherein the hydrogel comprises a reaction product of: a monomer; and a polyether macromer selected from poly(ethylene glycol) di-acrylamide, poly(ethylene glycol) di-acrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, derivatives thereof, or combinations thereof; and a flexible carrier member having a diameter and configured to house the elongated hydrogel within the diameter, and wherein the flexible carrier member includes at least one gap configured to allow the expanded hydrogel to expand into the at least one gap. 2 . The device according to claim 1 , wherein the polyether macromer has a molecular weight of about 400 grams/mole to about 35,000 grams/mole. 3 . The device according to claim 1 , wherein the monomer includes at least one pH sensitive ionizable functional group. 4 . The device according to claim 3 , wherein the at least one pH sensitive ionizable functional group includes a basic group. 5 . The device according to claim 4 , wherein the basic group comprises an amine, derivatives thereof, or combinations thereof. 6 . The device according to claim 5 , wherein the basic functional group is configured to be deprotonated at pHs greater than the pKa or protonated at pHs less than the pKa of the functional group. 7 . The device according to claim 3 , wherein the at least one pH sensitive ionizable functional group includes an acidic group. 8 . The device according to claim 7 , wherein the acidic group comprises a carboxylic acid, derivatives thereof, or combinations thereof. 9 . The device according to claim 8 , wherein the acidic functional group is configured to be protonated at pHs less than the pKa or de-protonated at pHs greater than the pKa of the functional groups. 10 . The device according to claim 7 , wherein the monomer is acrylic acid, methacrylic acid, or a salt thereof. 11 . The device according to claim 1 , wherein the polyether macromer is poly(ethylene glycol) di-acrylamide. 12 . The device according to claim 1 , wherein the elongated hydrogel is substantially free of acrylamide. 13 . The device according to claim 1 , wherein the polyether macromer is cross-linked with at least one ethylenically unsaturated compound. 14 . The device according to claim 1 , wherein the polyether macromer is cross-linked with N,N′-methylenebisacrylamide, derivatives thereof, or combinations thereof. 15 . The device according to claim 1 , wherein the elongated hydrogel comprises a reaction product of the monomer, the polyether macromer, and an initiator. 16 . The device according to claim 15 , wherein the initiator is selected from N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, derivatives thereof, or combinations thereof. 17 . The device according to claim 1 , wherein the elongated hydrogel is substantially non-resorbable. 18 . The device according to claim 1 , wherein the flexible carrier member is metallic. 19 . The device according to claim 1 , wherein the flexible carrier member is polymeric. 20 . The device according to claim 1 , wherein the at least one gap is between 0.00025″ and 0.005″.

Assignees

Inventors

Classifications

  • Hydrogels or hydrocolloids · CPC title

  • having a mesh structure (A61B17/1214 takes precedence) · CPC title

  • Metals or alloys · CPC title

  • Coils or wires · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016166258A1 cover?
Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.
Who is the assignee on this patent?
Microvention Inc
What technology area does this patent fall under?
Primary CPC classification A61B17/1219. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).